Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v1-EN
Language English English
Date Updated 2025-04-17 2024-10-21
Drug Identification Number 02483394 02483394
Brand name IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
Common or Proper name IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients SALBUTAMOL IPRATROPIUM BROMIDE SALBUTAMOL IPRATROPIUM BROMIDE
Strength(s) 2.5MG 0.5MG 2.5MG 0.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 20 x 2.5 mL ampoules 20 x 2.5 mL ampoules
ATC code R03AL R03AL
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2024-10-21 2024-10-21
Estimated end date 2025-04-30 2024-12-15
Actual end date 2025-04-16
Shortage status Resolved Anticipated shortage
Tier 3 Status Yes No
Company comments (L) 470425, 470525, 470625
Health Canada comments